Two Air India pilots failed preliminary drug tests and have been grounded pending further investigation [1].
The incident raises concerns regarding aviation safety and the effectiveness of crew screening protocols within one of India's largest carriers. Because pilots are responsible for hundreds of passengers, any breach of psychoactive substance policies triggers immediate regulatory and internal scrutiny.
Air India de-rostered the two pilots [1] after they returned non-negative results during preliminary screenings. The airline has sent the samples for confirmatory testing to verify the initial findings [3]. This action follows an incident linked to a flight between Phuket and Delhi [2].
The carrier instituted airline-wide psychoactive substance screening after a previous positive test was recorded [2]. This systemic sweep is intended to ensure aviation safety and maintain strict adherence to flight crew health standards [3].
Under aviation safety protocols, pilots who fail initial screenings are removed from flight duties immediately to prevent any risk to passengers or aircraft. The confirmatory test serves as the final legal and medical determination of whether a prohibited substance was present in the pilots' systems [3].
Air India has not released the specific names of the pilots or the types of substances detected in the preliminary rounds. The airline continues to conduct its internal review while awaiting the final lab results [1].
“Two Air India pilots failed preliminary drug tests and have been grounded.”
This development indicates a tightening of safety oversight at Air India following a pattern of substance-related failures. By moving from targeted tests to airline-wide screening, the carrier is attempting to mitigate systemic risk and restore regulatory confidence in its crew management. The outcome of the confirmatory tests will determine if these pilots face permanent termination or regulatory sanctions.
